Icon

PROTONIX IV (nda020988)- (EQ 40MG BASE/VIAL)

PANTOPRAZOLE SODIUM WYETH PHARMS
EQ 40MG BASE/VIAL
Yes No
2022-May-17 Expired
None None
None No
PROTONIX is a proton pump inhibitor (PPI) indicated in adults for the following: • Short-term treatment (7 to 10 days) of gastroesophageal reflux disease (GERD) associated with a history of Erosive Esophagitis (EE). • Pathological hypersecretion conditions including Zollinger-Ellison (ZE) Syndrome.
10 0 9
Total Other Developers None
Drugs with Suitability No
EQ 40MG BASE/VIAL ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** ****** ***** ****** ************ ******* *********** ****-***, **** **: *, ** ** **, ***, ** ** **, ****, *****, ***, ************ *******, ********** ******, **********, ********* ******, ***** (***) ***
****** ***** ****** ******** ****** ******* ******* *** *********** ****-*, ****** **. ***, ***, ***, *** ** *** ******** *******, ********* ******, **********, ********* ******, ***** (***) ***
****** ******** ******** ******** ******** ******* ************** **., *** *********** *** ********* ****, ********, ******** ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** ****** **. *** - ***, *** & ***, **** ************* ***** *****, *. *. *****, ******** ****, ******** - ************* ******, ******* - ********** ********, *********, ********* ******, ***** (***) ***
****** ****** ****** ****** ******* *********** ****** **. ***, ******* ****, ***** ***
****** ***** ******* ******* ***. *********** *** ******* **, *********, ******* *** ***, ****** (***) ***
****** ***** ************ ******, *.*. *********** ***** ** ************ (* * **** ******), *, **** ******, ****** *****, ***** (***) ***
****** ** ****** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ******** ******* ****-****** *********** ************** **.,***. (*** ****) *********** **, ** ***** ****, ******* **** *** *** ********** *********** **** ******* ******, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.